Abstract
Background and aim
DNA methylation plays an important role during colorectal cancer (CRC) carcinogenesis. DNA methyltransferase 1 (DNMT1) is responsible for maintaining DNA methylation. We addressed the significance of DNMT1 expression in CRC.
Materials and methods
We measured the expression of DNMT1 in CRC tissues and in their corresponding distal normal colorectal mucosa using reverse transcriptase-polymerase chain reaction and immunohistochemical analysis.
Results
The mean ± SD of DNMT1 mRNA in CRC tissues was 1.04 ± 0.36, which was significantly higher than that in their corresponding distal normal colorectal mucosa (0.58 ± 0.44, P < 0.05). Fifty-eight out of 77 (75.3%) CRC tissues and only 30 out of 77 (39%) corresponding distant normal colorectal mucosa showed immunoreactivity (P < 0.001). We also found that the immunoreactivity of DNMT1 was higher in mucosa adjacent to cancer than in corresponding normal colorectal mucosa; high immunoreactivity was significantly correlated with poor differentiation in CRC tissues (P = 0.008). No significant associations were found between DNMT1 immunoreactivity and the following variables: age, sex, locations of cancer, Duke’s phase, and the presence of lymph-node metastasis.
Conclusion
These findings suggested that DNMT1 was associated with the malignant phenotype, and dysregulation of DNMT1 expression was present in tumor cells of CRC.
Similar content being viewed by others
References
Jones PA, Baylin SB (2002) The fundamental role of epigenetic events in cancer. Nat Rev Genet 3:415–428
Jones PA, Laird PW (1999) Cancer epigenetics comes of age. Nat Genet 21:163–167
Kanai Y, Ushijima S, Tsuda H, Sakamoto M, Hirohashi S (2000) Aberrant DNA methylation precedes loss of heterozygosity on chromosome 16 in chronic hepatitis and liver cirrhosis. Cancer Lett 148:73–80
Kondo Y, Kanai Y, Sakamoto M, Mizokami M, Ueda R, Hirohashi S (2000) Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosis—a comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on 8 CpG islands in microdissected specimens from patients with hepatocellular carcinoma. Hepatology 32:970–979
Ueki T, Toyota M, Sohn T, Yeo CJ, Issa JP, Hruban RH, Goggins M (2000) Hypermethylation of multiple genes in pancreatic adenocarcinoma. Cancer Res 60:1835–1839
Shen JC, Rideout WM, Jones PA (1992) High frequency mutagenesis by a DNA methyltransferase. Cell 71:1073–1080
Momparler R, Bovenzi (2000) DNA methylation and cancer. J Cell Physiol 183:145–154
Chen RZ, Pettersson U, Beard C, Jackson-Grusby L, Jaenisch R (1998) DNA hypomethylation leads to elevated mutation rates. Nature 54:89–93
Zhang J, Lai MD, Chen J (1999) Methylation status of p16 gene in colorectal carcinoma and normal colorectal mucosa. World J Gastroenterol 5:451–454
Zhu YM, Lin J, Huang Q, Lai MD (2003) Screening the differentially methylated DNA sequences of colorectal cancer by methylated CpG islands amplification coupled with representational difference analysis. Chin J Med Genet 20:425–429
Yen RW, Vertino PM, Nelkin BD, Yu JJ, El-Deiry W, Cumaraswamy A et al (1999) Isolation and characterization of the cDNA encoding human DNA methyltransferase. Nucleic Acids Res 59:5438–5442
Leonhardt H, Page AW, Weier H (1992) A targeting sequence directs DNA methyltransferase to sites of DNA replication in mammalian nuclei. Cell 71:865–873
Pradhan S, Bacolla A, Wells RD, Roberts RJ (1999) Recombinant human DNA (cytosine-5) methyltransferase. I. Expression, purification, and comparison of de novo and maintenance methylation. J Biol Chem 274:33002–33010
Robertson KD (2001) DNA methylation, methyltransferases, and cancer. Oncogene 20:3139–3155
Issa JP, Vertino PM, Wu J, Sazawal S, Celano P, Nelkin BD et al (1993) Increased cytosine DNA-methyltransferase activity during colon cancer progression. J Natl Cancer Inst 85:1235–1240
Sun L, Hui AM, Kanai Y, Sakamoto M, Hirohashi S (1997) Increased DNA methyltransferase expression is associated with an early stage of human hepatocarcinogenesis. Jpn J Cancer Res 88:1165–1170
Saito Y, Kanai Y, Sakamoto M, Saito H, Ishii H, Hirohashi S (2001) Expression of mRNA for DNA methyltransferases and methyl-CpG-binding proteins and DNA methylation status on CpG islands and pericentromeric satellite regions during human hepatocarcinogenesis. Hepatology 33:561–568
Kanai Y, Ushijima S, Kondo Y, Nakanishi Y, Hirohashi S (2001) DNA methyltransferase expression and DNA methylation of CpG islands and pericentromeric satellite regions in human colorectal and stomach cancers. Int J Cancer 91:205–212
Eads CA, Danenberg KD, Kawakami K, Saltz LB, Danenberg PV, Laird PW (1999) CpG island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression. Cancer Res 59:2302–2306
Paz MF, Wei S, Cigudosa JC, Rodriguez-Perales S, Peinado MA, Huang TH, Esteller M (2003) Genetic unmasking of epigenetically silenced tumor suppressor genes in colon cancer cells deficient in DNA methyltransferases. Hum Mol Genet 12:2209–2219
De Marzo AM, Marchi VL, Yang ES, Veeraswamy R, Lin X, Nelson WG (1999) Abnormal regulation of DNA methyltransferase expression during colorectal. Carcinogenesis. Cancer Res 59:3855–3860
Choi MS, Shim YH, Hwa JY, Lee SK, Ro JY, Kim JS et al (2003) Expression of DNA methyltransferases in multistep hepatocarcinogenesis. Hum Pathol 34:11–17
Peng DF, Kanai Y, Sawada M, Ushijima S, Hiraoka N, Kosuge T et al (2005) Increased DNA methyltransferase 1 (DNMT1) protein expression in precancerous conditions and ductal carcinomas of the pancreas. Cancer Sci 96:403–408
Nakagawa T, Kanai Y, Saito Y, Kitamura T, Kakizoe T, Hirohashi S (2003) Increased DNA methyltransferase 1 protein expression in human transitional cell carcinoma of the bladder. J Urol 170:2463–2466
Etoh T, Kanai Y, Ushijima S, Nakagawa T, Nakanishi Y, Sasako M et al (2004) Increased DNA methyltransferase 1 (DNMT1) protein expression correlates significantly with poorer tumor differentiation and frequent DNA hypermethylation of multiple CpG islands in gastric cancers. Am J Pathol 164:689–699
Saito Y, Kanai Y, Nakagawa T, Sakamoto M, Saito H, Ishii H, Hirohashi S (2003) Increased protein expression of DNA methyltransferase (DNMT) 1 is significantly correlated with the malignant potential and poor prognosis of human hepatocellular carcinomas. Int J Cancer 105(4):527–532
Esteller M (2002) CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene 21:5427–5440
Wu J, Herman JG, Wilson G, Lee RY, Yen RW, Mabry M et al (1996) Expression of prokaryotic Hha I DNA methyltransferase is transforming and lethal to NIH 3T3 cells. Cancer Res 56:616–622
Bestor TH (2000) The DNA methyltransferase of mammals. Hum Mol Genet 9:2395–2402
Ting AH, Jair K, Suzuki H, Yen RC, Baylin SB, Schuebel KE (2004) Mammalian DNA methyltransferase 1: inspiration for new directions. Cell Cycle 3:1024–1026
Rhee I, Jair KW, Lengauer C, Herman JG, Kinzler KW, Vogelstein B (2000) CpG methylation is maintained in human cancer cells lacking DNMT1. Nature 404:1003–1007
Acknowledgments
We thank Dr. Tamara K. Locke for his scientific editing. This study was supported by the National Natural Science Foundation of China, No. 30070343.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zhu, YM., Huang, Q., Lin, J. et al. Expression of human DNA methyltransferase 1 in colorectal cancer tissues and their corresponding distant normal tissues. Int J Colorectal Dis 22, 661–666 (2007). https://doi.org/10.1007/s00384-006-0224-4
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00384-006-0224-4